Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    BMS-562247-01, Apixaban

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 3,460Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Registrant Name Registration No. Compound Registration Date Manufacturer Manufacturer's Country Manufacturer's Address
    29/11/2025 Polpharma
    Poland
    		 Wooshin Labotech Co., Ltd. Su172-5-ND(1) Apixaban 2020-09-04 Pharmaceutical Works Polpharma S.A. Poland 19. Pelplinska Str, 83-200 Starogard Gdanski, Poland
    29/11/2025 Dr. Reddy\'s Laboratories
    India
    		 Pamirae Co., Ltd. Su574-12-ND Apixaban 2019-01-17 Dr. Reddy's Laboratories Limited India CTO-SEZ Process Unit-01, Sector No. 28 & 34, Devunipalavalasa Village, Srikakulam District Andhra Pradesh, India.